Thomas, McNerney raises first fund

Thomas, McNerney & Partners raised $216 million for its first fund, which will invest in companies of all stages in medical device, biotech and pharmaceutical sectors. The fund also will seek later-stage spinout opportunities. The firm typically will seek to lead financings, and estimates it will invest $10-$20 million per company. ...